Nakamura, Minoru <br/><br/>
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.  [electronic resource] 

 -  Journal of hepatology  Mar 2005 
 - 386-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0168-8278 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2004.11.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies--blood<br/>Biomarkers--blood<br/>Disease-Free Survival<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Liver Cirrhosis, Biliary--blood<br/>Liver Function Tests<br/>Liver Transplantation--physiology<br/>Male<br/>Membrane Glycoproteins--immunology<br/>Middle Aged<br/>Nuclear Pore Complex Proteins<br/>Nuclear Proteins--immunology<br/>Peptide Fragments--immunology<br/>Probability<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome<br/>Ursodeoxycholic Acid--therapeutic use